UGANDA HIV/TB COHRE TRAiNING PROGRAM
乌干达艾滋病毒/结核病培训项目
基本信息
- 批准号:7209822
- 负责人:
- 金额:$ 39.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-28 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcquired Immunodeficiency SyndromeAddressAfricaAreaCaringClinicalCollaborationsCountryDiseaseEnsureEpidemicEvidence based practiceFaceFutureGoalsGovernmentHIVHealth PolicyHealth Services ResearchHealth care facilityHumanHuman ResourcesIndividualInfectionInstitutionInterventionJointsLaboratoriesLeadershipLeprosyLifeManaged CareOperative Surgical ProceduresOther ResourcesPatientsPolicy DevelopmentsPreventionPrevention programPrivate SectorPublic HealthResearchResearch InfrastructureResearch Project GrantsResourcesScientistTrainingTraining ProgramsTranslatingTuberculosisUgandaUniversitiesVirus DiseasesWorkantiretroviral therapydevelopment policydissemination researchforginghealth trainingmortalitypreventprogramsresearch and developmentskills
项目摘要
"Despite notable achievements in preventing Human Immunodeficiency Virus (HIV) infection and treating AIDS over the past 10 years, Uganda still faces formidable challenges to control HIV in the country. The HIV infection is fueling Tuberculosis leading to HIV/TB dual epidemic. Tuberculosis (TB) remains the leading cause of mortality among People Living with HIV/AIDS in Uganda. The interaction of TB and HIV increases the burden of both diseases, which highlights the need for joint interventions to prevent, manage and care for HIV/TB co-infection. This creates a major challenge for human, financial and infrastructural resources to reduce the burden of HIV/TB infections in Uganda. Likewise, there is need to optimize the available manpower and other resources through identifying priority areas for human capacity development, research and infrastructural improvement that are crucial for prevention and management of HIV and TB infections. Major challenges are manifested by the limited capacity to carry out clinical, biomedical, operations and health services research projects that are essential in addressing the HIV/TB epidemic. In addition, there is lack of scientific leadership to promote HIV/TB management, to harness the efforts of the individual different players in the area of HIV and TB care so that they work jointly, and to develop the research, clinical and prevention programme agenda. There is imperfect dissemination of research findings on HIV/TB infections, inadequate utilization of research findings for policy development and delayed incorporation of evidence-based practices on HIV/TB management into routine practice.
One key step in the rebuilding of the Ugandan public health infrastructure to tackle the HIV/TB epidemic is to forge strong collaborations between research institutions, Non-Government organizations, government ministries and the private sector. The JCRC is a research and health care facility devoted to caring for HIV patients and has led the way in opening Africa to antiretroviral therapy. Through the years, the JCRC has formed strong collaborations with Case Western Reserve University (CWRU) USA, the National Tuberculosis and Leprosy Programme (NTLP), Makerere and Mbarara Universities. The goal of the proposed training program is to strengthen the national capacity to address the clinical, public health and scientific challenges of the evolving HIV and TB epidemics in Uganda through training in clinical, operational and health services research. The training program will build on ongoing projects on HIV and TB, and will extend the findings of these studies to the public health and policy arena. The goals will be met through a coherent program of degree and non-degree training in collaboration with CWRU.
"
尽管在预防人类免疫缺陷病毒(HIV)感染和治疗辅助方面取得了显着成就,但乌干达仍然面临着控制该国的艾滋病毒的巨大挑战。艾滋病毒感染正在加剧结核病,导致HIV/TB Dual Dual Promentic Promentic。增加了这两种疾病的负担,这突出了对艾滋病毒/结核病的共同干预的需求,这对人类,财务和基础设施的主要挑战构成了一个主要的挑战。艾滋病毒和结核病感染的管理。此外,缺乏科学领导来促进艾滋病毒/结核病管理,以利用艾滋病毒和结核病领域的各个不同参与者的努力,以便他们共同工作,并制定研究,临床和预防计划议程。关于艾滋病毒/结核病感染的研究结果的传播不完美,对政策制定的研究结果的利用不足以及延迟纳入了基于循证的艾滋病毒/结核病管理实践,使其纳入常规实践中。
重建乌干达公共卫生基础设施以应对艾滋病毒/结核病流行的关键一步是在研究机构,非政府组织,政府部和私营部门之间建立强有力的合作。 JCRC是一种研究和医疗机构,致力于照顾艾滋病毒患者,并导致非洲开放抗逆转录病毒疗法。多年来,JCRC与Case Western Reserve University(CWRU),国家结核和麻风病计划(NTLP),Makerere和Mbarara大学建立了强有力的合作。拟议的培训计划的目的是通过通过临床,运营和卫生服务研究培训培训乌干达的艾滋病毒和结核病流行病的临床,公共卫生和科学挑战的国家能力。培训计划将基于艾滋病毒和结核病正在进行的项目,并将这些研究的发现扩展到公共卫生和政策领域。目标将通过与CWRU合作的一致学位和非学位培训计划实现。
“
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER N MUGYENYI其他文献
PETER N MUGYENYI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER N MUGYENYI', 18)}}的其他基金
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 39.46万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686541 - 财政年份:2023
- 资助金额:
$ 39.46万 - 项目类别:
Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami
预测撒哈拉以南非洲艾滋病毒流行率的年龄变化:应对银色海啸的必要流行病学步骤
- 批准号:
10762075 - 财政年份:2023
- 资助金额:
$ 39.46万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 39.46万 - 项目类别:
Identification of small molecule inhibitors of the DDI2 protease
DDI2 蛋白酶小分子抑制剂的鉴定
- 批准号:
10638837 - 财政年份:2023
- 资助金额:
$ 39.46万 - 项目类别: